What is the Org number of CARDIOMYOCYTE AS?

CARDIOMYOCYTE AS is registered with Brønnøysundsregistrene under Org 927976900.

What is the revenue of CARDIOMYOCYTE AS?

CARDIOMYOCYTE AS reported revenue of NOK 9,1M in 2024.

How many employees does CARDIOMYOCYTE AS have?

CARDIOMYOCYTE AS employs 3 people as of the latest annual report.

Who is the CEO of CARDIOMYOCYTE AS?

Even Holt is Chief Executive Officer of CARDIOMYOCYTE AS, in role since 2021.

Where is CARDIOMYOCYTE AS headquartered?

CARDIOMYOCYTE AS's registered address is Bærumsveien 337B, 1344 Haslum.

CARDIOMYOCYTE AS

ASActive

Org 927976900Bærumsveien 337B, 1344 HaslumMedical specialists activities · NACE 8622Est. 20213 employees

Full Risika report

Revenue 2024

NOK 9,1M

+2% vs 2023

EBITDA margin

29.2%

+14% vs 2023

Equity ratio

3.4%

Financial strength

Net profit 2024

NOK 2M

+14% vs 2023

EBITDA — year on yearNOK millions

Key figuresAnnual report 2024

Revenue	NOK 9,1M	+2%
EBITDA	NOK 2,7M	+14%
Net profit	NOK 2M	+14%
Total assets	NOK 3,3M	+11%
Equity	NOK 114K	+28%
Employees	3	—

Item	2021	2022	2023	2024
Revenue	8 801	8 728	8 887	9 069
Staff expenses	−1 966	−2 000	−2 065	−1 981
EBITDA	2 509	2 351	2 323	2 650
Depreciation & amort.	−24	−22	−53	−58
EBIT	2 485	2 329	2 270	2 593
Net financials	120	73	0	4
Profit before tax	2 605	2 403	2 270	2 596
Tax	549	514	500	572
Net profit	2 056	1 889	1 770	2 025

Item	2021	2022	2023	2024
Total assets	4 103	3 005	3 010	3 343
Equity	30	119	89	114
Long-term debt	0	0	0	0
Short-term debt	4 072	2 886	2 921	3 229
Total debt	4 072	2 886	2 921	3 229

Name	Role	Member since	Age	Other directorships
EH Even Holt Chief Executive Officer	Chief Executive Officer	2021	—	—

Shareholder	Type	Ownership	Votes	Since
Spqr As	Company	100.0%	100.0%	2024

Person	Role here	Other companies
Even Holt	Chief Executive Officer	0 companies

CARDIOMYOCYTE AS

ASActive

Org 927976900Bærumsveien 337B, 1344 HaslumMedical specialists activities · NACE 8622Est. 20213 employees

Full Risika report

Revenue 2024

NOK 9,1M

+2% vs 2023

EBITDA margin

29.2%

+14% vs 2023

Equity ratio

3.4%

Financial strength

Net profit 2024

NOK 2M

+14% vs 2023

EBITDA — year on yearNOK millions

Key figuresAnnual report 2024

Revenue	NOK 9,1M	+2%
EBITDA	NOK 2,7M	+14%
Net profit	NOK 2M	+14%
Total assets	NOK 3,3M	+11%
Equity	NOK 114K	+28%
Employees	3	—